Buradasınız

Anasayfa » Content

Lipid profile variations before and after diethyl carbamazine citrate (dec) treatment in filariasis

Journal Name:

  • Indian Journal of Basic & Applied Medical Research

Publication Year:

  • 2014

Key Words:

Author Name
Abstract (2. Language): 
Lymphatic Filariasis is a disabling and Disfiguring disease affecting mankind since antiquity. It is a debilitating disease attaching social stigma to afflicted people living in most of the tropical countries in the world. This infection is prevalent in both urban and rural areas. Lymphoedema is a common clinical problem in India. This is endemic in many parts of our country. As lymphoedema is the commonst clinical manifestation of filariasis, there exits a vast number of patients afflicted by this crippling disease. Repeated attacks of fever, lymphangitis and lymphadenitis are accompanied by progressive oedema of the limbs. This is associated with fibrosis and thickening of the skin resulting in the hideous looking limbs often called Elephantiasis 1.There are no reports on the status of lipids in filariasis. Hence the present study is under taken to estimate the levels of lipid fractions interfiarncé in the disease process, and the variations in these parameters before and after DEC treatment.
Bookmark/Search this post with
FULL TEXT (PDF): 
PDF icon arastirmax-lipid-profile-variations-and-after-diethyl-carbamazine-citrate-dec-treatment-filariasis.pdf
  • 3
32
39
  • English

REFERENCES

References: 

1 Ahuja MMS.,(1976) : Progress In clinical Medicine Vol 1, Armold Heinnemann, p. 25.
1. Park J.E., and Park. K .,(2013) Text book of Preventive and social Medicine, 23thEdition M/S Baarasi das
publishers,India.
2. Sharma,RS.,(1996): filariasis problem in India and the current control strategy in NICD (Ed). Revised Strategy for
control of lymphatic filariasis in India NIDC:Delhi 10
3. ICMR Bulletin (2002):mathematical models for optimizing and predicting outcomes cf intervention measures for the
control of Lymphatic Filariasis, vol-3,No1; 1-8
38
Indian Journal of Basic and Applied Medical Research; June 2014: Vol.-3, Issue- 3, P. 32-39
33
www.ijbamr.com P ISSN: 2250-284X , E ISSN : 2250-2858
4. Haarbrink M, Terhell AJ, Abadi Gk, Mitsui Y,Yazdanbakhsh M, (1999). Trans R Soc Trop Med Hyg (1999) .
Adverse reactions following diethylcarbamazine (DEC) intake in endemic normals, microfilaraemics and
elephantiasis patients. Jan-Feb-93(1):91-6,
5. National filarial control programme operational manual (1995). Directorate. NMEP, Delhi.
6. ICMR Bulletin (2002): Prospects of elimination of lymphatic Filaraisis in India.Vol.32.No.5&6:41-52
7. Tietz,N W(Ed).Text book of Clinical Chemisty,W B.Saunders,2012 ,5th Edition.
8. T.John Zachariah & R.Kaleysa Raj (1986) effect of diethylcarbazine on lipid metabolisum of setaria
digitata.indian.j.Med,Res 83; 41-45

Thank you for copying data from http://www.arastirmax.com